nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Docetaxel—head and neck cancer	0.379	0.469	CbGbCtD
Olmesartan—ABCC2—Vinblastine—head and neck cancer	0.235	0.291	CbGbCtD
Olmesartan—ABCC2—Docetaxel—head and neck cancer	0.194	0.24	CbGbCtD
Olmesartan—Lupus erythematosus—Hydroxyurea—head and neck cancer	0.00672	0.035	CcSEcCtD
Olmesartan—Gastric irritation—Hydroxyurea—head and neck cancer	0.00646	0.0336	CcSEcCtD
Olmesartan—Epigastric discomfort—Hydroxyurea—head and neck cancer	0.00476	0.0248	CcSEcCtD
Olmesartan—Systemic lupus erythematosus—Hydroxyurea—head and neck cancer	0.00452	0.0235	CcSEcCtD
Olmesartan—Bone marrow depression—Hydroxyurea—head and neck cancer	0.00371	0.0193	CcSEcCtD
Olmesartan—Lupus erythematosus—Docetaxel—head and neck cancer	0.00349	0.0182	CcSEcCtD
Olmesartan—Bone pain—Vinblastine—head and neck cancer	0.00287	0.0149	CcSEcCtD
Olmesartan—Hyperuricaemia—Hydroxyurea—head and neck cancer	0.0027	0.014	CcSEcCtD
Olmesartan—Hepatic enzyme increased—Hydroxyurea—head and neck cancer	0.00265	0.0138	CcSEcCtD
Olmesartan—Blood uric acid increased—Hydroxyurea—head and neck cancer	0.00255	0.0133	CcSEcCtD
Olmesartan—Blood urea increased—Hydroxyurea—head and neck cancer	0.00236	0.0123	CcSEcCtD
Olmesartan—Systemic lupus erythematosus—Docetaxel—head and neck cancer	0.00235	0.0122	CcSEcCtD
Olmesartan—Renal failure acute—Hydroxyurea—head and neck cancer	0.00197	0.0102	CcSEcCtD
Olmesartan—Pharyngolaryngeal pain—Docetaxel—head and neck cancer	0.00193	0.01	CcSEcCtD
Olmesartan—Laryngeal pain—Docetaxel—head and neck cancer	0.00191	0.00993	CcSEcCtD
Olmesartan—Face oedema—Hydroxyurea—head and neck cancer	0.00175	0.00913	CcSEcCtD
Olmesartan—Blood creatinine increased—Hydroxyurea—head and neck cancer	0.0017	0.00886	CcSEcCtD
Olmesartan—Angina pectoris—Vinblastine—head and neck cancer	0.00168	0.00873	CcSEcCtD
Olmesartan—Pancytopenia—Vinblastine—head and neck cancer	0.00164	0.00851	CcSEcCtD
Olmesartan—Rhinorrhoea—Docetaxel—head and neck cancer	0.00161	0.00835	CcSEcCtD
Olmesartan—Pancreatitis—Hydroxyurea—head and neck cancer	0.00154	0.00801	CcSEcCtD
Olmesartan—Pancytopenia—Hydroxyurea—head and neck cancer	0.00149	0.00776	CcSEcCtD
Olmesartan—Neutropenia—Hydroxyurea—head and neck cancer	0.00147	0.00764	CcSEcCtD
Olmesartan—Agranulocytosis—Vinblastine—head and neck cancer	0.00143	0.00746	CcSEcCtD
Olmesartan—Hyperbilirubinaemia—Docetaxel—head and neck cancer	0.00143	0.00744	CcSEcCtD
Olmesartan—Infestation NOS—Hydroxyurea—head and neck cancer	0.0014	0.00729	CcSEcCtD
Olmesartan—Infestation—Hydroxyurea—head and neck cancer	0.0014	0.00729	CcSEcCtD
Olmesartan—Blood bilirubin increased—Docetaxel—head and neck cancer	0.00138	0.00715	CcSEcCtD
Olmesartan—Pharyngitis—Vinblastine—head and neck cancer	0.00137	0.00712	CcSEcCtD
Olmesartan—Bone pain—Docetaxel—head and neck cancer	0.00136	0.00706	CcSEcCtD
Olmesartan—Lethargy—Fluorouracil—head and neck cancer	0.00133	0.00695	CcSEcCtD
Olmesartan—Influenza like illness—Docetaxel—head and neck cancer	0.00126	0.00657	CcSEcCtD
Olmesartan—Alopecia—Vinblastine—head and neck cancer	0.00122	0.00634	CcSEcCtD
Olmesartan—Nasopharyngitis—Fluorouracil—head and neck cancer	0.00117	0.00609	CcSEcCtD
Olmesartan—Lightheadedness—Docetaxel—head and neck cancer	0.00116	0.00605	CcSEcCtD
Olmesartan—Angiopathy—Hydroxyurea—head and neck cancer	0.00114	0.00593	CcSEcCtD
Olmesartan—Eosinophilia—Fluorouracil—head and neck cancer	0.00112	0.00582	CcSEcCtD
Olmesartan—Ill-defined disorder—Vinblastine—head and neck cancer	0.00111	0.00579	CcSEcCtD
Olmesartan—Alopecia—Hydroxyurea—head and neck cancer	0.00111	0.00578	CcSEcCtD
Olmesartan—Anaemia—Vinblastine—head and neck cancer	0.00111	0.00577	CcSEcCtD
Olmesartan—Angina pectoris—Fluorouracil—head and neck cancer	0.0011	0.00573	CcSEcCtD
Olmesartan—Malaise—Vinblastine—head and neck cancer	0.00108	0.00563	CcSEcCtD
Olmesartan—Vertigo—Vinblastine—head and neck cancer	0.00108	0.00561	CcSEcCtD
Olmesartan—Leukopenia—Vinblastine—head and neck cancer	0.00107	0.00559	CcSEcCtD
Olmesartan—Pancytopenia—Fluorouracil—head and neck cancer	0.00107	0.00559	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.00105	0.00547	CcSEcCtD
Olmesartan—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.00103	0.00537	CcSEcCtD
Olmesartan—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.00102	0.00528	CcSEcCtD
Olmesartan—Pneumonia—Fluorouracil—head and neck cancer	0.00101	0.00528	CcSEcCtD
Olmesartan—Anaemia—Hydroxyurea—head and neck cancer	0.00101	0.00526	CcSEcCtD
Olmesartan—Discomfort—Vinblastine—head and neck cancer	0.00101	0.00525	CcSEcCtD
Olmesartan—Infestation NOS—Fluorouracil—head and neck cancer	0.00101	0.00524	CcSEcCtD
Olmesartan—Infestation—Fluorouracil—head and neck cancer	0.00101	0.00524	CcSEcCtD
Olmesartan—Malaise—Hydroxyurea—head and neck cancer	0.000987	0.00514	CcSEcCtD
Olmesartan—Urinary tract infection—Fluorouracil—head and neck cancer	0.00098	0.0051	CcSEcCtD
Olmesartan—Leukopenia—Hydroxyurea—head and neck cancer	0.00098	0.0051	CcSEcCtD
Olmesartan—Lethargy—Docetaxel—head and neck cancer	0.000963	0.00501	CcSEcCtD
Olmesartan—Thrombocytopenia—Vinblastine—head and neck cancer	0.000959	0.00499	CcSEcCtD
Olmesartan—Hyponatraemia—Docetaxel—head and neck cancer	0.000948	0.00493	CcSEcCtD
Olmesartan—Sinusitis—Fluorouracil—head and neck cancer	0.000946	0.00492	CcSEcCtD
Olmesartan—Pain in extremity—Docetaxel—head and neck cancer	0.000944	0.00491	CcSEcCtD
Olmesartan—Agranulocytosis—Fluorouracil—head and neck cancer	0.000941	0.00489	CcSEcCtD
Olmesartan—Anorexia—Vinblastine—head and neck cancer	0.000934	0.00486	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000925	0.00481	CcSEcCtD
Olmesartan—Discomfort—Hydroxyurea—head and neck cancer	0.000921	0.00479	CcSEcCtD
Olmesartan—Rhinitis—Fluorouracil—head and neck cancer	0.000907	0.00472	CcSEcCtD
Olmesartan—Pharyngitis—Fluorouracil—head and neck cancer	0.000898	0.00467	CcSEcCtD
Olmesartan—Oedema—Hydroxyurea—head and neck cancer	0.000893	0.00465	CcSEcCtD
Olmesartan—Infection—Hydroxyurea—head and neck cancer	0.000887	0.00462	CcSEcCtD
Olmesartan—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000876	0.00456	CcSEcCtD
Olmesartan—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000875	0.00455	CcSEcCtD
Olmesartan—Skin disorder—Hydroxyurea—head and neck cancer	0.000868	0.00451	CcSEcCtD
Olmesartan—Orthostatic hypotension—Docetaxel—head and neck cancer	0.000862	0.00449	CcSEcCtD
Olmesartan—Anorexia—Hydroxyurea—head and neck cancer	0.000851	0.00443	CcSEcCtD
Olmesartan—Decreased appetite—Vinblastine—head and neck cancer	0.000851	0.00443	CcSEcCtD
Olmesartan—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.00085	0.00442	CcSEcCtD
Olmesartan—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.00085	0.00442	CcSEcCtD
Olmesartan—Nasopharyngitis—Docetaxel—head and neck cancer	0.000844	0.00439	CcSEcCtD
Olmesartan—Pain—Vinblastine—head and neck cancer	0.000838	0.00436	CcSEcCtD
Olmesartan—Constipation—Vinblastine—head and neck cancer	0.000838	0.00436	CcSEcCtD
Olmesartan—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000833	0.00433	CcSEcCtD
Olmesartan—Arrhythmia—Fluorouracil—head and neck cancer	0.000808	0.00421	CcSEcCtD
Olmesartan—Feeling abnormal—Vinblastine—head and neck cancer	0.000807	0.0042	CcSEcCtD
Olmesartan—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000801	0.00417	CcSEcCtD
Olmesartan—Alopecia—Fluorouracil—head and neck cancer	0.0008	0.00416	CcSEcCtD
Olmesartan—Angina pectoris—Docetaxel—head and neck cancer	0.000795	0.00414	CcSEcCtD
Olmesartan—Dyspepsia—Hydroxyurea—head and neck cancer	0.000786	0.00409	CcSEcCtD
Olmesartan—Decreased appetite—Hydroxyurea—head and neck cancer	0.000776	0.00404	CcSEcCtD
Olmesartan—Pancytopenia—Docetaxel—head and neck cancer	0.000775	0.00403	CcSEcCtD
Olmesartan—Abdominal pain—Vinblastine—head and neck cancer	0.000774	0.00403	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.000771	0.00401	CcSEcCtD
Olmesartan—Fatigue—Hydroxyurea—head and neck cancer	0.00077	0.00401	CcSEcCtD
Olmesartan—Pain—Hydroxyurea—head and neck cancer	0.000764	0.00397	CcSEcCtD
Olmesartan—Constipation—Hydroxyurea—head and neck cancer	0.000764	0.00397	CcSEcCtD
Olmesartan—Neutropenia—Docetaxel—head and neck cancer	0.000763	0.00397	CcSEcCtD
Olmesartan—Vision blurred—Fluorouracil—head and neck cancer	0.000742	0.00386	CcSEcCtD
Olmesartan—Feeling abnormal—Hydroxyurea—head and neck cancer	0.000736	0.00383	CcSEcCtD
Olmesartan—Pneumonia—Docetaxel—head and neck cancer	0.000732	0.00381	CcSEcCtD
Olmesartan—Anaemia—Fluorouracil—head and neck cancer	0.000728	0.00379	CcSEcCtD
Olmesartan—Infestation NOS—Docetaxel—head and neck cancer	0.000728	0.00379	CcSEcCtD
Olmesartan—Infestation—Docetaxel—head and neck cancer	0.000728	0.00379	CcSEcCtD
Olmesartan—Renal failure—Docetaxel—head and neck cancer	0.000715	0.00372	CcSEcCtD
Olmesartan—Jaundice—Docetaxel—head and neck cancer	0.000709	0.00369	CcSEcCtD
Olmesartan—Body temperature increased—Hydroxyurea—head and neck cancer	0.000706	0.00367	CcSEcCtD
Olmesartan—Leukopenia—Fluorouracil—head and neck cancer	0.000705	0.00367	CcSEcCtD
Olmesartan—Asthenia—Vinblastine—head and neck cancer	0.000703	0.00366	CcSEcCtD
Olmesartan—Agranulocytosis—Docetaxel—head and neck cancer	0.000679	0.00353	CcSEcCtD
Olmesartan—Chest pain—Fluorouracil—head and neck cancer	0.000671	0.00349	CcSEcCtD
Olmesartan—Myalgia—Fluorouracil—head and neck cancer	0.000671	0.00349	CcSEcCtD
Olmesartan—Diarrhoea—Vinblastine—head and neck cancer	0.00067	0.00349	CcSEcCtD
Olmesartan—Discomfort—Fluorouracil—head and neck cancer	0.000663	0.00345	CcSEcCtD
Olmesartan—Rhinitis—Docetaxel—head and neck cancer	0.000655	0.00341	CcSEcCtD
Olmesartan—Pharyngitis—Docetaxel—head and neck cancer	0.000648	0.00337	CcSEcCtD
Olmesartan—Dizziness—Vinblastine—head and neck cancer	0.000648	0.00337	CcSEcCtD
Olmesartan—Urinary tract disorder—Docetaxel—head and neck cancer	0.000645	0.00336	CcSEcCtD
Olmesartan—Oedema peripheral—Docetaxel—head and neck cancer	0.000643	0.00335	CcSEcCtD
Olmesartan—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000643	0.00335	CcSEcCtD
Olmesartan—Oedema—Fluorouracil—head and neck cancer	0.000643	0.00335	CcSEcCtD
Olmesartan—Connective tissue disorder—Docetaxel—head and neck cancer	0.000642	0.00334	CcSEcCtD
Olmesartan—Asthenia—Hydroxyurea—head and neck cancer	0.000641	0.00333	CcSEcCtD
Olmesartan—Urethral disorder—Docetaxel—head and neck cancer	0.00064	0.00333	CcSEcCtD
Olmesartan—Infection—Fluorouracil—head and neck cancer	0.000639	0.00332	CcSEcCtD
Olmesartan—Nervous system disorder—Fluorouracil—head and neck cancer	0.00063	0.00328	CcSEcCtD
Olmesartan—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000629	0.00328	CcSEcCtD
Olmesartan—Tachycardia—Fluorouracil—head and neck cancer	0.000627	0.00326	CcSEcCtD
Olmesartan—Vomiting—Vinblastine—head and neck cancer	0.000623	0.00324	CcSEcCtD
Olmesartan—Headache—Vinblastine—head and neck cancer	0.000614	0.00319	CcSEcCtD
Olmesartan—Anorexia—Fluorouracil—head and neck cancer	0.000613	0.00319	CcSEcCtD
Olmesartan—Diarrhoea—Hydroxyurea—head and neck cancer	0.000611	0.00318	CcSEcCtD
Olmesartan—Hypotension—Fluorouracil—head and neck cancer	0.000601	0.00313	CcSEcCtD
Olmesartan—Angiopathy—Docetaxel—head and neck cancer	0.000593	0.00308	CcSEcCtD
Olmesartan—Dizziness—Hydroxyurea—head and neck cancer	0.000591	0.00307	CcSEcCtD
Olmesartan—Mediastinal disorder—Docetaxel—head and neck cancer	0.000589	0.00306	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.000586	0.00305	CcSEcCtD
Olmesartan—Arrhythmia—Docetaxel—head and neck cancer	0.000583	0.00304	CcSEcCtD
Olmesartan—Nausea—Vinblastine—head and neck cancer	0.000582	0.00303	CcSEcCtD
Olmesartan—Insomnia—Fluorouracil—head and neck cancer	0.000581	0.00303	CcSEcCtD
Olmesartan—Alopecia—Docetaxel—head and neck cancer	0.000577	0.003	CcSEcCtD
Olmesartan—Mental disorder—Docetaxel—head and neck cancer	0.000572	0.00298	CcSEcCtD
Olmesartan—Malnutrition—Docetaxel—head and neck cancer	0.000569	0.00296	CcSEcCtD
Olmesartan—Vomiting—Hydroxyurea—head and neck cancer	0.000568	0.00295	CcSEcCtD
Olmesartan—Dyspepsia—Fluorouracil—head and neck cancer	0.000566	0.00294	CcSEcCtD
Olmesartan—Rash—Hydroxyurea—head and neck cancer	0.000563	0.00293	CcSEcCtD
Olmesartan—Dermatitis—Hydroxyurea—head and neck cancer	0.000563	0.00293	CcSEcCtD
Olmesartan—Headache—Hydroxyurea—head and neck cancer	0.00056	0.00291	CcSEcCtD
Olmesartan—Decreased appetite—Fluorouracil—head and neck cancer	0.000559	0.00291	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000555	0.00289	CcSEcCtD
Olmesartan—Back pain—Docetaxel—head and neck cancer	0.00055	0.00286	CcSEcCtD
Olmesartan—Pain—Fluorouracil—head and neck cancer	0.00055	0.00286	CcSEcCtD
Olmesartan—Muscle spasms—Docetaxel—head and neck cancer	0.000547	0.00284	CcSEcCtD
Olmesartan—Nausea—Hydroxyurea—head and neck cancer	0.000531	0.00276	CcSEcCtD
Olmesartan—Feeling abnormal—Fluorouracil—head and neck cancer	0.00053	0.00276	CcSEcCtD
Olmesartan—Anaemia—Docetaxel—head and neck cancer	0.000526	0.00273	CcSEcCtD
Olmesartan—Urticaria—Fluorouracil—head and neck cancer	0.000511	0.00266	CcSEcCtD
Olmesartan—Syncope—Docetaxel—head and neck cancer	0.00051	0.00265	CcSEcCtD
Olmesartan—Leukopenia—Docetaxel—head and neck cancer	0.000509	0.00265	CcSEcCtD
Olmesartan—Body temperature increased—Fluorouracil—head and neck cancer	0.000508	0.00264	CcSEcCtD
Olmesartan—Palpitations—Docetaxel—head and neck cancer	0.000502	0.00261	CcSEcCtD
Olmesartan—Loss of consciousness—Docetaxel—head and neck cancer	0.0005	0.0026	CcSEcCtD
Olmesartan—Cough—Docetaxel—head and neck cancer	0.000496	0.00258	CcSEcCtD
Olmesartan—Arthralgia—Docetaxel—head and neck cancer	0.000484	0.00252	CcSEcCtD
Olmesartan—Myalgia—Docetaxel—head and neck cancer	0.000484	0.00252	CcSEcCtD
Olmesartan—Chest pain—Docetaxel—head and neck cancer	0.000484	0.00252	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000481	0.0025	CcSEcCtD
Olmesartan—Oedema—Docetaxel—head and neck cancer	0.000464	0.00241	CcSEcCtD
Olmesartan—Anaphylactic shock—Docetaxel—head and neck cancer	0.000464	0.00241	CcSEcCtD
Olmesartan—Infection—Docetaxel—head and neck cancer	0.000461	0.0024	CcSEcCtD
Olmesartan—Shock—Docetaxel—head and neck cancer	0.000457	0.00238	CcSEcCtD
Olmesartan—Nervous system disorder—Docetaxel—head and neck cancer	0.000455	0.00237	CcSEcCtD
Olmesartan—Pruritus—Fluorouracil—head and neck cancer	0.000455	0.00237	CcSEcCtD
Olmesartan—Thrombocytopenia—Docetaxel—head and neck cancer	0.000454	0.00236	CcSEcCtD
Olmesartan—Tachycardia—Docetaxel—head and neck cancer	0.000453	0.00236	CcSEcCtD
Olmesartan—Skin disorder—Docetaxel—head and neck cancer	0.000451	0.00235	CcSEcCtD
Olmesartan—Anorexia—Docetaxel—head and neck cancer	0.000442	0.0023	CcSEcCtD
Olmesartan—Diarrhoea—Fluorouracil—head and neck cancer	0.00044	0.00229	CcSEcCtD
Olmesartan—Hypotension—Docetaxel—head and neck cancer	0.000434	0.00226	CcSEcCtD
Olmesartan—Dizziness—Fluorouracil—head and neck cancer	0.000425	0.00221	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000423	0.0022	CcSEcCtD
Olmesartan—Insomnia—Docetaxel—head and neck cancer	0.00042	0.00218	CcSEcCtD
Olmesartan—Vomiting—Fluorouracil—head and neck cancer	0.000409	0.00213	CcSEcCtD
Olmesartan—Dyspepsia—Docetaxel—head and neck cancer	0.000408	0.00213	CcSEcCtD
Olmesartan—Rash—Fluorouracil—head and neck cancer	0.000405	0.00211	CcSEcCtD
Olmesartan—Dermatitis—Fluorouracil—head and neck cancer	0.000405	0.00211	CcSEcCtD
Olmesartan—Decreased appetite—Docetaxel—head and neck cancer	0.000403	0.0021	CcSEcCtD
Olmesartan—Headache—Fluorouracil—head and neck cancer	0.000403	0.0021	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000401	0.00208	CcSEcCtD
Olmesartan—Fatigue—Docetaxel—head and neck cancer	0.0004	0.00208	CcSEcCtD
Olmesartan—Pain—Docetaxel—head and neck cancer	0.000397	0.00206	CcSEcCtD
Olmesartan—Constipation—Docetaxel—head and neck cancer	0.000397	0.00206	CcSEcCtD
Olmesartan—Feeling abnormal—Docetaxel—head and neck cancer	0.000382	0.00199	CcSEcCtD
Olmesartan—Nausea—Fluorouracil—head and neck cancer	0.000382	0.00199	CcSEcCtD
Olmesartan—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000379	0.00197	CcSEcCtD
Olmesartan—Abdominal pain—Docetaxel—head and neck cancer	0.000367	0.00191	CcSEcCtD
Olmesartan—Body temperature increased—Docetaxel—head and neck cancer	0.000367	0.00191	CcSEcCtD
Olmesartan—Asthenia—Docetaxel—head and neck cancer	0.000333	0.00173	CcSEcCtD
Olmesartan—Pruritus—Docetaxel—head and neck cancer	0.000328	0.00171	CcSEcCtD
Olmesartan—Diarrhoea—Docetaxel—head and neck cancer	0.000317	0.00165	CcSEcCtD
Olmesartan—Dizziness—Docetaxel—head and neck cancer	0.000307	0.0016	CcSEcCtD
Olmesartan—Vomiting—Docetaxel—head and neck cancer	0.000295	0.00154	CcSEcCtD
Olmesartan—Rash—Docetaxel—head and neck cancer	0.000293	0.00152	CcSEcCtD
Olmesartan—Dermatitis—Docetaxel—head and neck cancer	0.000292	0.00152	CcSEcCtD
Olmesartan—Headache—Docetaxel—head and neck cancer	0.000291	0.00151	CcSEcCtD
Olmesartan—Nausea—Docetaxel—head and neck cancer	0.000276	0.00143	CcSEcCtD
